Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
J Stroke Cerebrovasc Dis ; 31(9): 106648, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35863262

ABSTRACT

INTRODUCTION: Diabetes mellitus is a well-known risk factor for ischemic stroke and is associated with unfavorable outcome after stroke. Metformin is recommended as first-line treatment in these patients. Pre-stroke metformin use might have neuroprotective properties resulting in reduced stroke severity. However, results of the effects of pre-stroke metformin use on functional outcome are conflicting and has not been previously described in patients with type 2 diabetes mellitus regardless of stroke severity or revascularization treatment. In this study, we aimed to assess the association between metformin use and functional outcome in patients with type 2 diabetes mellitus and acute ischemic stroke. METHODS: We used data from patients with known type 2 diabetes mellitus who were admitted with acute ischemic stroke between 2017 and 2021 in the Isala Hospital Zwolle and Medisch Spectrum Twente (MST) Enschede, the Netherlands. The association between pre-stroke metformin use and favorable functional outcome at 3 months (defined as modified Rankin Scale (mRS) < 3) was expressed as Odds Ratios (ORs) with corresponding confidence intervals (CIs). Adjustments were made for age, sex, hyperglycemia on admission and revascularization treatment by means of multiple logistic regression. RESULTS: Nine hundred thirty seven patients were included of whom 592 patients (63%) used metformin. Six hundred seventy eight (74%) patients were hyperglycemic on admission. Median mRS was 3 (IQR 2-6) and 593 patients (63%) had a favorable outcome. Pre-stroke metformin use was associated with favorable outcome (aOR of 1.94 (95%- CI 1.45-2.59)). CONCLUSION: In this study, we showed that pre-stroke metformin use was associated with favorable outcome after acute ischemic stroke in patients with diabetes mellitus type 2.


Subject(s)
Brain Ischemia , Diabetes Mellitus, Type 2 , Ischemic Stroke , Metformin , Stroke , Brain Ischemia/complications , Brain Ischemia/diagnosis , Brain Ischemia/drug therapy , Diabetes Mellitus, Type 2/complications , Diabetes Mellitus, Type 2/diagnosis , Diabetes Mellitus, Type 2/drug therapy , Humans , Metformin/adverse effects , Stroke/diagnosis , Stroke/drug therapy , Stroke/etiology , Treatment Outcome
2.
J Neurol ; 266(3): 782-789, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30291423

ABSTRACT

INTRODUCTION: We aimed to disprove an in-hospital off-hour effect in stroke patients by adjusting for disease severity and poor prognostic findings on imaging. PATIENTS AND METHODS: Our study included 5378 patients from a single center prospective stroke registry of a large teaching hospital in the Netherlands, admitted between January 2003 and June 2015. Patients were categorized by admission time, off-hours (OH) or working hours (WH). The in-hospital mortality, 7-day mortality, unfavorable functional outcome (modified Rankin scale > 2) and discharge to home were analyzed. Results were adjusted for age, sex, stroke severity (NIHSS score) and unfavorable findings on imaging of the brain (midline shift and dense vessel sign). RESULTS: Overall, 2796 patients (52%) were admitted during OH, which had a higher NIHSS score [3 (IQR 2-8) vs. 3 (IQR 2-6): p < 0.01] and had more often a dense vessel sign at admission (7.9% vs. 5.4%: p < 0.01). There was no difference in mortality between the OH-group and WH-group (6.2% vs. 6.0%; p = 0.87). The adjusted hazard ratio of in-hospital mortality during OH was 0.87 (95% CI: 0.70-1.08). Analysis of 7-day mortality showed similar results. Unadjusted, the OH-group had an unfavorable outcome [OR: 1.14 (95% CI: 1.02-1.27)] and could less frequently be discharged to home [OR: 1.16 (95% CI: 1.04-1.29)], which was no longer present after adjustment. DISCUSSION AND CONCLUSIONS: The overall outcome of stroke patients admitted to a large Dutch teaching hospital is not influenced by time of admission. When studying OH effects, adjustment for disease severity and poor prognostic findings on imaging is crucial before drawing conclusions on staffing and material.


Subject(s)
Outcome Assessment, Health Care/statistics & numerical data , Patient Admission/statistics & numerical data , Patient Discharge/statistics & numerical data , Registries/statistics & numerical data , Severity of Illness Index , Stroke , Aged , Aged, 80 and over , Cohort Studies , Female , Hospital Mortality , Humans , Male , Middle Aged , Netherlands/epidemiology , Stroke/diagnostic imaging , Stroke/mortality , Stroke/physiopathology , Stroke/therapy , Time Factors
3.
Seizure ; 51: 52-54, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28797915

ABSTRACT

PURPOSE: Uncertainty about recurrence after a first unprovoked seizure is a significant psychological burden for patients, and motivates the need for diagnostic tools with high sensitivity and specificity to assess recurrence risk. As the sensitivity of a routine EEG after a first unprovoked seizure is limited, patients often require further diagnostics. Here, we study if ambulatory EEG (aEEG) has similar diagnostic accuracy as sleep deprived EEG (sdEEG). METHODS: In this retrospective cohort, we included patients with an unprovoked first seizure and a normal routine EEG who subsequently underwent an sdEEG or aEEG. All EEGs were reviewed for the presence of interictal epileptiform discharges (IEDs). We calculated specificity and sensitivity of sdEEG and aEEG, using the clinical diagnosis of epilepsy as golden standard. All patients had a follow-up of one year. RESULTS: We included 104 patients. Sensitivities for sdEEG and aEEG were 45% (specificity 91%) and 63% (specificity 95%), respectively. Independent risk factor for recurrent seizure were IEDs on the additional EEG, with a relative risk of 1.5 of having a recurrent seizure within a year. CONCLUSION: Diagnostic accuracies of sdEEG and aEEG are similar and depending on patients' and clinicians' preference both can be considered in patients with a first seizure and a normal routine EEG to determine recurrence risk.


Subject(s)
Electroencephalography/methods , Seizures/diagnosis , Adult , Aged , Cohort Studies , Female , Humans , Male , Middle Aged , Monitoring, Ambulatory/methods , Recurrence , Retrospective Studies , Sensitivity and Specificity , Sleep Deprivation
4.
Neurology ; 78(7): 493-8, 2012 Feb 14.
Article in English | MEDLINE | ID: mdl-22302552

ABSTRACT

OBJECTIVES: New insights in the pathophysiology of lacunar stroke (LS) suggest that it is caused by increased permeability of the blood-brain barrier due to endothelial activation. Because endothelial cells are the major production and storage site of tissue factor pathway inhibitor (TFPI), this protein can be used as marker of endothelial activation. In this observational study we measured the different pools of TFPI, as a marker of endothelial function, in first-ever lacunar stroke patients. METHODS: We determined antigen levels of total and free full-length (FL) TFPI using ELISA in 149 patients and 42 controls. Heparin-releasable free FL TFPI was determined in a random subset of 17 patients and 15 controls. By brain MRI, we classified LS patients as having isolated lacunar infarct (ILA) or silent ischemic lesions (SILs). RESULTS: Plasma levels of total TFPI were highest in patients with SILs compared with those with ILA, but this association disappeared after correction for age and levels of low-density lipoprotein cholesterol. However, levels of heparin-releasable free FL TFPI were higher in patients than in controls. CONCLUSIONS: Although ambient plasma levels of total TFPI were not different in subtypes of LS, the increased levels of heparin-releasable TFPI in patients suggest a role of endothelial activation in the pathogenesis of LS.


Subject(s)
Anticoagulants/pharmacology , Heparin/pharmacology , Lipoproteins/metabolism , Stroke, Lacunar/metabolism , Age Factors , Aged , Biomarkers , Brain Ischemia/metabolism , Brain Ischemia/pathology , Clinical Protocols , Denmark , Endothelium, Vascular/physiology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Image Processing, Computer-Assisted , Logistic Models , Magnetic Resonance Imaging , Male , Middle Aged , Prospective Studies , Registries , Risk Factors , Stroke, Lacunar/classification
5.
Cerebrovasc Dis ; 30(3): 285-9, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20664262

ABSTRACT

BACKGROUND: A striatocapsular infarct (SCI) is a subcortical infarct in the territory of the lenticulostriate arteries, most likely due to transient occlusion of the main stem of the middle cerebral artery (MCA). Presence of the hyperdense middle cerebral artery sign (HMCAS) is a reliable marker of occlusion of the MCA. We hypothesized that SCIs are related to HMCAS at baseline, which subsequently disappears (HMCAS-D) on follow-up CT in stroke patients treated with intravenous rtPA. METHODS: Baseline and 24-hour follow-up CTs were evaluated for HMCAS in acute ischemic stroke patients treated with intravenous rtPA and follow-up scans were also reviewed for the presence of isolated cortical (CIn), SCI, cortical and striatocapsular (CI-SCI) or lacunar infarct. We determined the incidence of SCI and the association between SCI and HMCAS on baseline and follow-up CT. RESULTS: Of the 247 patients, 43 had an SCI (17.4%; 95% CI: 13.1-22.5). The presence of HMCAS at baseline was related to the occurrence of infarction with involvement of the striatocapsular region (SCI or CI-SCI) on follow-up CT (OR: 11.6; 95% CI: 5.9-22.8). HMCAS-D on follow-up scans was significantly related to SCI on follow-up CT compared to CI-SCI (OR: 4.9; 95% CI: 3.7-6.1). CONCLUSIONS: Occurrence of SCI and CI-SCI is associated with the presence of HMCAS on CT before thrombolysis, whereas HMCAS-D on follow-up CT is strongly related to the occurrence of SCI. Our findings support the causative role of transient occlusion of the MCA main stem in the pathogenesis of SCI.


Subject(s)
Cerebral Infarction/diagnostic imaging , Middle Cerebral Artery/diagnostic imaging , Stroke/drug therapy , Thrombolytic Therapy/methods , Tissue Plasminogen Activator/therapeutic use , Aged , Aged, 80 and over , Cerebral Infarction/etiology , Cerebral Infarction/physiopathology , Female , Follow-Up Studies , Humans , Injections, Intravenous , Male , Middle Aged , Middle Cerebral Artery/drug effects , Middle Cerebral Artery/physiopathology , Retrospective Studies , Stroke/physiopathology , Tissue Plasminogen Activator/administration & dosage , Tissue Plasminogen Activator/pharmacology , Tomography, X-Ray Computed
6.
Cerebrovasc Dis ; 29(5): 503-7, 2010.
Article in English | MEDLINE | ID: mdl-20299791

ABSTRACT

BACKGROUND: Metabolic syndrome (MetS) is a cluster of three or more of the following risk factors: obesity, elevated blood pressure, elevated triglyceride level, elevated glucose level, and low high-density lipoprotein level. Lacunar infarcts (LS) account for 25% of all ischemic strokes and are small, deeply located brain infarcts. Two different subtypes exist, which are distinguished by the presence of concomitant white matter lesions (WML) on brain imaging. We determined the prevalence of MetS in LS and the association between MetS with LS subtypes in a series of first-ever LS patients. METHODS: We included 92 patients with a first-ever LS, and 92 patients with a first-ever atheroslerotic cortical stroke (CS) matched for age and sex. LS subtypes were defined according to presence of concomitant WML. We defined MetS retrospectively according to previously defined standards. RESULTS: 35.9% of LS patients and 45.7% of CS patients had MetS (OR 0.67; 95% CI 0.37-1.20). MetS was more prevalent in LS without WML than in LS with WML (44.4 and 23.7%, respectively; OR 2.98; 95% CI 1.04-8.47). Similarly, MetS related more to CS compared to LS with WML (OR 2.56; 95% CI 1.03-6.37). CONCLUSION: MetS relates more strongly to LS without WML and to CS, than to LS with WML. Our results suggest a different underlying mechanism between LS without WML and CS, and lacunar stroke with WML.


Subject(s)
Brain Infarction/pathology , Brain/pathology , Metabolic Syndrome/complications , Stroke/pathology , Aged , Aged, 80 and over , Brain Infarction/classification , Brain Infarction/epidemiology , Case-Control Studies , Female , Humans , Magnetic Resonance Imaging , Male , Metabolic Syndrome/epidemiology , Middle Aged , Multivariate Analysis , Prevalence , Retrospective Studies , Risk Factors , Stroke/classification , Stroke/epidemiology
7.
Curr Neurovasc Res ; 6(1): 32-41, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19355924

ABSTRACT

Cerebral small vessel disease results in silent ischemic lesions (SIL) among which is leukoaraiosis. In this process, endothelial damage is probably involved. Endothelial progenitor cells (EPC), are involved in endothelial repair. By restoring the damaged endothelium, EPC could mitigate SIL and cerebral small vessel disease. Haptoglobin 1-1, one of three phenotypes of haptoglobin, relates to SIL and may therefore attenuate the endothelial repair by EPC. Our aim was to quantify EPC number and function and to assess haptoglobin phenotype and its effect on EPC function in patients with a high prevalence of SIL: lacunar stroke patients. We assessed EPC In 42 lacunar stroke patients and 18 controls by flow cytometry and culture with fetal calf serum, patient and control serum. We determined haptoglobin phenotype and cultured EPC with the three different haptoglobin phenotypes. We found that EPC cluster counts were lower in patients (96.9 clusters/well +/- 83.4 (mean +/- SD)), especially in those with SIL (85.0 +/- 64.3), than in controls (174.4 +/- 112.2). Cluster formation was inhibited by patient serum, especially by SIL patient serum, but not by control serum. Patients with haptoglobin 1-1 had less clusters in culture, and when haptoglobin 1-1 was added to EPC cultures, cluster numbers were lower than with the other haptoglobin phenotypes. We conclude that lacunar stroke patients, especially those with SIL, have impaired EPC cluster formation, which may point at decreased endothelial repair potential. The haptoglobin 1-1 phenotype is likely a causative factor in this impairment.


Subject(s)
Adult Stem Cells/physiology , Brain Infarction/pathology , Cerebrovascular Disorders/pathology , Endothelium/pathology , Haptoglobins/metabolism , Phenotype , Adult Stem Cells/drug effects , Aged , Antigens, CD/metabolism , Brain/pathology , Brain Infarction/etiology , Cells, Cultured , Cerebrovascular Disorders/complications , Female , Flow Cytometry , Haptoglobins/pharmacology , Humans , Magnetic Resonance Imaging/methods , Male , Middle Aged , Retrospective Studies , Risk Factors
8.
J Neurol ; 255(5): 692-6, 2008 May.
Article in English | MEDLINE | ID: mdl-18286319

ABSTRACT

BACKGROUND AND PURPOSE: Virchow-Robin spaces (VRs) are perivascular spaces surrounding the deep perforating brain arteries. VRs dilatation is pathologic, and it could be a manifestation of cerebral small vessel disease. In the present study we assessed the relation between VRs and silent ischemic lesions in a cohort of patients with cerebral small vessel disease. METHODS: We divided dilated VRs on MRI (1.5 Tesla) into three semi-quantitative categories in 165 first ever lacunar stroke patients. We counted asymptomatic lacunar infarcts and graded white matter lesions, and compared the prevalence of vascular risk factors in different categories of VRs. We also determined independent predictors of silent ischemic lesions. RESULTS: VRs at basal ganglia level related to age, hypertension, asymptomatic lacunar infarcts, and white matter lesions. VRs at basal ganglia level predicted silent ischemic lesions (odds ratio 10.58 per higher VRs category; 95 %- confidence interval 3.40 - 32.92). CONCLUSION: Dilated VRs in the basal ganglia relate to the severity of cerebral small vessel disease and might be a manifestation of the same small vessel abnormality that causes silent ischemic lesions. This adds a role for VRs as a potential marker for small vessel disease.


Subject(s)
Arterioles/pathology , Brain Ischemia/pathology , Cerebral Arteries/pathology , Cerebrovascular Disorders/pathology , Microcirculation/pathology , Aged , Arterioles/physiopathology , Blood-Brain Barrier/pathology , Blood-Brain Barrier/physiopathology , Brain Infarction/pathology , Brain Infarction/physiopathology , Brain Ischemia/physiopathology , Cerebral Arteries/physiopathology , Cerebrovascular Disorders/physiopathology , Dilatation, Pathologic/pathology , Disease Progression , Extracellular Space/physiology , Female , Humans , Magnetic Resonance Imaging , Male , Microcirculation/physiopathology , Middle Aged , Predictive Value of Tests , Prognosis , Risk Factors , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...